Jaguar Health Inc (NASDAQ:JAGX) price closed lower on Monday, May 06, dropping -0.31% below its previous close.
A look at the daily price movement shows that the last close reads $0.32. The company’s 5Y monthly beta was ticking 1.38. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.22 and 52-week low of $0.05. The stock added 277.38% on its value in the past month.
Jaguar Health Inc, which has a market valuation of $87.56 million, is expected to release its quarterly earnings report May 13, 2024 – May 17, 2024.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give JAGX a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that JAGX’s price is at present 86.01% off the SMA20 and 176.63% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 82.96, with weekly volatility standing at 26.46%. The indicator jumps to 26.26% when calculated based on the past 30 days. Jaguar Health Inc (NASDAQ:JAGX)’s beta value is holding at 0.85, while the average true range (ATR) indicator is currently reading 0.04.
An analysis of the Jaguar Health Inc (NASDAQ:JAGX) stock in terms of its daily trading volume indicates that the 3-month average is 67.34 million.
Current records show that the company has 276.22M in outstanding shares. The insiders’ percentage holdings are 4.90% of outstanding shares while the percentage share held by institutions stands at 0.74%. But the 109.38% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
